课题基金 / 基金详情

The use of CRISPR-scaring and single cell approaches to study mammary epithelial cell differentiation dynamics in health and disease

The use of CRISPR-scaring and single cell approaches to study mammary epithelial cell differentiation dynamics in health and disease
使用 CRISPR 惊吓和单细胞方法研究健康和疾病中乳腺上皮细胞分化动态
批准号:
BB/S006745/1
负责人:
Walid Khaled
金额:
$66.62万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

Walid Khaled的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Each organ in our body is composed of millions of cells. However, not all the cells within an organ are the same, they all have a defined role and fate which cumulatively dictates the function of the organ. The mammary gland is one of the defining organs that distinguishes mammals from other organisms. The primary role of the mammary gland is to produce and secrete milk to nurture new-born mammals. Just like any other organ the mammary gland is composed of multiple cell types each with a defined role and fate. Understanding how these different cell types relate to each other and contribute to development of disease is required. It is only within the last 5 years has it become technically feasible to identify which genes are active within a single cell. We have recently used this novel technology to profile 23,000 individual mammary cells and determine their identity and chart their fate. We found that we can divide the 23,000 cells in to 15 different groups based on their identity. We also found that there is a hierarchical structure to these 15 different groups of cells. Some groups were only found during milk production (lactation) while other cells were found in all stages and are capable of giving rise to most of the other types of cells. We call these cells progenitor cells. Further, we found that these progenitors maintain a "memory" of having undergone pregnancy which possibly facilitates milk production in subsequent pregnancy. Interestingly, it is known that an early pregnancy substantially decreases a woman's risk to develop breast cancer during her life. In this proposed study we aim to build on the identification of these different groups of cells and utilise the single cell technology to further understand the changes in the progenitor population in response to ageing, pregnancy and its role in cancer development.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41467-021-21783-3
发表时间: 2021-03-09
期刊: Nature communications
影响因子: 16.6
作者: [Bach K, Pensa S, Zarocsinceva M, Kania K, Stockis J, Pinaud S, Lazarus KA, Shehata M, Simões BM, Greenhalgh AR, Howell SJ, Clarke RB, Caldas C, Halim TYF, Marioni JC, Khaled WT]
通讯作者: Khaled WT
Transcriptional changes in the mammary gland during lactation revealed by single cell sequencing of cells from human milk.
乳腺过程中乳腺的转录变化显示,通过人牛奶的细胞单细胞测序揭示了。
DOI: 10.1038/s41467-021-27895-0
发表时间: 2022-01-28
期刊: Nature communications
影响因子: 16.6
作者: [Twigger AJ, Engelbrecht LK, Bach K, Schultz-Pernice I, Pensa S, Stenning J, Petricca S, Scheel CH, Khaled WT]
通讯作者: Khaled WT
Time-resolved single-cell analysis of Brca1 associated mammary tumourigenesis reveals aberrant differentiation of luminal progenitors
Brca1 相关乳腺肿瘤发生的时间分辨单细胞分析揭示腔祖细胞的异常分化
DOI: 10.17863/cam.65684
发表时间: 2021
期刊:
影响因子: --
作者: [Bach K]
通讯作者: Bach K
DOI: 10.1016/j.semcdb.2021.03.013
发表时间: 2021-06
期刊: Seminars in cell & developmental biology
影响因子: 7.3
作者: [Twigger AJ, Khaled WT]
通讯作者: Khaled WT
Charting cellular changes in the human breast associated with embryogenesis, parity, age, menopause and germline mutations
  • 批准号:
    MR/S036059/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $60.31万
  • 财政年份:
    2018
  • 负责人:
    Walid Khaled
  • 依托单位:
国内基金
海外基金
CRISPR驱动的自维持催化核酸网络用于AFB1的高保真检测
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    李香芝
  • 依托单位:
介入输注CRISPR-Cas9 构建的 SHP-1-KO T 细胞联合靶向肝癌细胞脂质代谢通路的协同抗肝癌机制研究
  • 批准号:
    2026JJ50324
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘华平
  • 依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
  • 批准号:
    2026JJ50010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    应站明
  • 依托单位:
基于 CRISPR/Cas13a 与熵驱动反应的多级信号放大电化学传感平台在胰腺炎复发标志物联合检测中的应用研究
  • 批准号:
    ZCLKLY26H2003
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    王旭耀
  • 依托单位: